DIO1 and ovarian serous adenocarcinoma: DIO1 diminished expression in high‐grade serous ovarian cancer, both in vitro and in human tissues, together with indications that high RNA expression positively correlates with patient's survival, led us to hypothesize that the enzyme may function as a tumor suppressor.